EV Group Witnesses Positive Momentum in the Korean MEMS Market

EV Group (EVG), a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that the RFID/USN Center has selected EVG's fully automated GEMINI(®) wafer bonding system for stacked 3D MEMS device development. Located in Incheon, Korea, RFID/USN is a leading MEMS foundry that offers manufacturing services for companies to initiate production processes with capabilities to segue from R+D to high volume. This order represents a significant win for EVG, marking its first foray into the prestigious institute's manufacturing line-up.

"As a foundry service provider, we strive to offer our customers with cutting-edge technologies to support their 3D MEMS production needs, and as such, require a flexible system that can adapt to a wide range of requirements," said RFID/USN Center's executive director, Dong-suk Han. "Given the stringent demands of the leading-edge MEMS market, particularly for 3D devices, we evaluated a number of bonding solutions on the market for MEMS production, and in the end, chose EVG's GEMINI not only for its superior reliability and high-volume capabilities, but also for its flexibility and extendibility. The GEMINI enables us to quickly adjust the chuck to handle both 6- and 8-inch wafers, offering the highest available uptime in the market to ensure around-the-clock operation--a significant factor in our decision."

Commenting on today's announcement, Paul Lindner, EVG's executive technology director noted, "This opportunity to cooperate with a leading Korean MEMS foundry, such as the RFID/USN Center, is an important step for EVG as we continue to expand our footprint in the growing Korean market. Following the opening of our Korean subsidiary in the summer of 2008, we have witnessed positive momentum in the market, and are fully committed to serving the needs of the region in the future. Lindner added, "We have long served the MEMS market, and this order win is further testament to the strength of our solutions to address the production demands of advanced technologies, such as 3D MEMS devices."

EVG's GEMINI platform is a field-proven, production manufacturing solution for high-volume wafer bonding applications for MEMS, 3D IC integration and advanced packaging, as well as compound semiconductor applications. Its modular design offers customers a highly flexible and extendible platform that enables customers the opportunity to incorporate pre-processing options such as cleaning and plasma activation modules, as well as additional bond chambers to augment throughput. Additionally, this fully automated wafer bonding system integrates EVG's SmartView(®) aligner, which yields precision alignment accuracy, as well as wafer handling expertise into one wafer bonding platform. The GEMINI maintains an installed base of more than 100, contributing to EVG's 75-percent market share dominance in wafer bonding.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    EV Group. (2021, September 07). EV Group Witnesses Positive Momentum in the Korean MEMS Market. AZoNano. Retrieved on October 10, 2024 from https://www.azonano.com/news.aspx?newsID=13876.

  • MLA

    EV Group. "EV Group Witnesses Positive Momentum in the Korean MEMS Market". AZoNano. 10 October 2024. <https://www.azonano.com/news.aspx?newsID=13876>.

  • Chicago

    EV Group. "EV Group Witnesses Positive Momentum in the Korean MEMS Market". AZoNano. https://www.azonano.com/news.aspx?newsID=13876. (accessed October 10, 2024).

  • Harvard

    EV Group. 2021. EV Group Witnesses Positive Momentum in the Korean MEMS Market. AZoNano, viewed 10 October 2024, https://www.azonano.com/news.aspx?newsID=13876.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.